Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
EMPLOYMENT OPPORTUNITY
New Research Specialist Laboratory Technician Position Available
KeViRx is a Charlottesville, Virginia, based early stage pharmaceutical company, and recently
received funding from the Commonwealth Research Commercialization Fund. We seek to fill an
R&D laboratory position to assist with this grant focused on developing new cancer
therapeutics. The ideal candidate would have a BS degree in Biology or Chemistry and
laboratory experience with biochemical assays, protein determinations, molecular biology
techniques, mammalian cell culturing methodologies and data analyses. More information
concerning KeViRx can be found on our website (www.kevirx.com). Individuals who are
interested in this position should contact Elizabeth R. Sharlow (ersharlow@kevirx.com).
EVENTS
VirginiaDrugDiscoveryRx: Targets to Translation
Double Tree Hotel, Midlothian, VA – May 18 – 19, 2020
The VaDDC Executive Committee regrets to announce this event has been canceled until next year due to the COVID-19 pandemic.
NEWS
VaDDC Executive Committee Member, Beth Sharlow Receives Promotion at UVA
Dr. Elizabeth Sharlow has been promoted to Professor of Research in Pharmacology effective July 1, 2020. More about Dr. Sharlow
Virginia Company, Phlow Corp. Awarded $354 million to Produce Ingredients for Covid-19 Drugs
A new Richmond-based pharmaceutical manufacturing company has received a $354 million federal contract to make the active ingredients for more than a dozen medicines used to treat patients with COVID-19. And the ingredients will be made at a pharmaceutical plant in...
Virginia Bio Names John Newby CEO
Virginia Bio announces John Newby will become CEO of Virginia Bio starting August 5, 2019. John will be stepping down as Commissioner of the Virginia Department of Veterans Services, where for the last 7 years he led this 800-member Agency located across more than 40...
AFFILIATES
Want to work with us?
If you are interested in supporting this initiative, please contact us.